Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06993454 · ClinicalTrials.gov registry record · NA

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

A NA study of Type 2 Diabetes and Hepatic Steatosis, sponsored by AdventHealth Translational Research Institute.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06993454 is a NA study of Type 2 Diabetes and Hepatic Steatosis that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 12 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06993454, a NA study of Type 2 Diabetes and Hepatic Steatosis, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).

Conditions Studied

Type 2 Diabetes Hepatic Steatosis

Interventions

  • OTHER Magnetic Resonance Liver Assessment
  • OTHER Bike Exercise VO2max
  • OTHER DEXA

Study Locations (1)

Florida

  • AdventHealth Translational Research Institute - Orlando

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-04-25
Est. Completion 2026-03
Phase NA

Sponsor

AdventHealth Translational Research Institute

54 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06993454

The ClinicalTrials.gov registry entry for NCT06993454 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Magnetic Resonance Liver Assessment is the first listed.

NCT06993454 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06993454 about?

NCT06993454 is a clinical study titled "Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis". The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).

What is the current status of trial NCT06993454?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-04-25. Estimated completion is 2026-03.

What conditions does trial NCT06993454 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Hepatic Steatosis.

What interventions are being tested in trial NCT06993454?

The interventions under investigation include: Magnetic Resonance Liver Assessment (OTHER), Bike Exercise VO2max (OTHER), DEXA (OTHER).

Who is sponsoring clinical trial NCT06993454?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06993454 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Hepatic Steatosis

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.